Gate Bioscience has raised $60 million to develop a new type of pill-based medicine — which it calls a molecular gate — that can go after...
Recent preclinical results indicate novel next-generation vaccine candidates developed at Cleveland Clinic protect against multiple strains of influenza...
Researchers developed an approach to cancer treatment that uses dimeric IgA antibodies to target and kill tumor-promoting molecules found deep within cancer...
Aragen Life Sciences is launching a new $30 million biologics manufacturing site in Bangalore due to growing demand, the India-based drug manufacturer...
New research from Memorial Sloan Kettering Cancer Center (MSK) identifies a promising immunotherapy target for acute myeloid leukemia; decodes genetic...
In this GEN Learning Lab, Anna Moberg from Cytiva will discuss applications for screening and characterizing antibody and antibody fragments in pure...
Adenoviral vaccines are widely used. We need to know why some people get deadly blood clots.
DURHAM, N.C. — For too long, cancer treatment has been a double-edged sword – the very treatments designed to kill cancer cells often wrought havoc...
Vir Biotechnology is best known for jumping into action during a crisis: It helped create an antibody during the Ebola outbreak and sprinted to make a...
An enzyme that may help some breast cancers spread can be stopped with an antibody created in the lab of Cold Spring Harbor Laboratory Professor Nicholas...
"There Is No Cure": Long-Forgotten Virus Could Return, US Is Not Prepared Authored by Jack Phillips via The Epoch Times (emphasis ours), The...
LOS ANGELES — An international Phase 3 clinical trial found that metastatic colorectal cancer patients with a rare genetic tumor mutation called KRAS...
At the recommended Phase II dose of 5x1011 particle units, six of 12 patients (50%) receiving PRGN-2012 achieved a complete response by no longer needing...
PfAP2-P serves as an essential regulator of multiple biological processes of the parasites. The protein acts as both a repressor of genes involved in immune...
Among a slew of emerging artificial intelligence biotech companies, BigHat has the potential to transform how next-generation antibodies are designed,...
The discovery of a malaria protein that helps the parasite grow inside red blood cells and plays a key regulatory role in the parasite’s immune evasion...
LOS ANGELES and PHOENIX — City of Hope®, one of the largest cancer research and treatment organizations in the United States, and TGen are leading an...
In this GEN webinar, Dr. Anne Goupil-Lamy from BIOVIA will discuss how machine learning and AI is accelerating the discovery of novel biotherapeutics,...
In this GEN webinar, Dr. Caitlin Hanna from Waters describes an automatable sample preparation protocol that simplifies peptide mapping and reduces long...
The number one thing most people fear as they age is developing dementia. As the world’s population becomes increasingly older, this is a growing public...
Researchers at the University of Cincinnati have developed a lateral flow assay that can detect bacterial toxins from Porphyromonas gingivalis, the causative...
Precision medicines are gaining increasing traction in healthcare. Here are five companies driving the field with recent approvals in RNA therapeutics,...
This study is conducted by the Jiangsu Provincial Center for Disease Control and Prevention, National Institute of Diagnostics and Vaccine Development...
The goal of mRNA technology is to harness the power of the cell to potentially prevent infections and treat diseases.
Cold Spring Harbor, NY – Cold Spring Harbor Laboratory Press (CSHL Press), a publisher of scientific books, journals, and electronic media, today announced...
In this GEN webinar, Dr. David Schriemer, niversity of Calgary) will present an innovative approach for applying HX-MS to protein analysis in biotherapeutics...
Only 2% Of Americans Have Received New COVID Vaccine: CDC Authored by Jack Phillips via The Epoch Times, About 2 percent of all Americans...
Lonza’s Synaffix is adding another manufacturing licensing partnership by securing a $740 million deal with Sotio Biotech, which would allow Sotio to...
Lonza’s Synaffix is adding another manufacturing licensing partnership by securing a $740 million deal with Sotio Biotech, which would allow Sotio to...
COVID-19 Vaccines 'May Trigger' Rheumatic Inflammatory Diseases: Study Authored by Marina Zhang via The Epoch Times (emphasis ours), A new...